Literature DB >> 20707791

The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.

Wolfgang Otto1, Stefan Denzinger, Hans-Martin Fritsche, Maximilian Burger, Wolf F Wieland, Ferdinand Hofstädter, Arndt Hartmann, Simone Bertz.   

Abstract

OBJECTIVE: To ascertain which of the currently defined World Health Organization (WHO) grading classifications of pT1 urothelial bladder cancer (BC), published in 1973 and 2004, is more suitable for predicting outcome. PATIENTS AND METHODS: Transurethral resection of the bladder (TURB) specimens of 310 patients with first diagnosis of initial pT1 BC were reassessed by three urological pathologists according to the WHO classifications of 1973 and 2004. The TURB procedure was followed by either immediate cystectomy or adjuvant bacille Calmette-Guérin (BCG) instillations. Kaplan-Meier analysis was used to compare survival rates of the different tumour grades (mean follow-up was 57 months).
RESULTS: According to the 1973 WHO classification, none of the pT1 BC specimens were graded as G1, while 36% were graded as G2 and 64% were graded as G3. Histological reassessment according to the 2004 WHO classification highlighted only 4% low-grade and 96% high-grade tumours. The 10-year cancer-specific survival rates of high-grade tumours (85%) were intermediate between G2 (96%) and G3 (78%).
CONCLUSIONS: The results of the present study support the presumption that the 1973 WHO classification is more suitable for predicting outcome for pT1 tumours, by defining at least two prognostic groups. A new classification should revise the definition of low- and high-grade pT1 BC to preserve the prognostic value of tumour grading.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20707791     DOI: 10.1111/j.1464-410X.2010.09515.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  22 in total

1.  Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.

Authors:  Peter C Rubenwolf; Wolfgang Otto; Stefan Denzinger; Ferdinand Hofstädter; Wolf Wieland; Nikolaos T Georgopoulos
Journal:  World J Urol       Date:  2014-08       Impact factor: 4.226

2.  Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Authors:  Soum D Lokeshwar; Roberto Ruiz-Cordero; Marie C Hupe; Merce Jorda; Mark S Soloway
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

3.  SIU-ICUD on bladder cancer: pathology.

Authors:  Eva Compérat; Marek Babjuk; Ferran Algaba; Mahul Amin; Fadi Brimo; David Grignon; Donna Hansel; Ondra Hes; Bernard Malavaud; Victor Reuter; Theo van der Kwast
Journal:  World J Urol       Date:  2018-09-14       Impact factor: 4.226

4.  [Non-invasive and invasive urothelial tumours: special challenges in uropathological diagnostics].

Authors:  N T Gaisa; K Lindemann-Docter
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

5.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

6.  Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.

Authors:  Bas W G van Rhijn; Mireia Musquera; Liyang Liu; André N Vis; Tahlita C M Zuiverloon; Geert J L H van Leenders; Wim J Kirkels; Ellen C Zwarthoff; Egbert R Boevé; Adriaan C Jöbsis; Bharati Bapat; Michael A S Jewett; Alexandre R Zlotta; Theo H van der Kwast
Journal:  Mod Pathol       Date:  2014-11-28       Impact factor: 7.842

7.  Bladder cancer: validity of the 2004 system for grading Ta bladder cancer.

Authors:  Maximilian Burger; Peter J Goebell
Journal:  Nat Rev Urol       Date:  2012-02-14       Impact factor: 14.432

8.  WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.

Authors:  Wolfgang Otto; Johannes Breyer; Sonja Herdegen; Fabian Eder; Simone Bertz; Matthias May; Roman Mayr; Eva M Lausenmeyer; Stefan Denzinger; Bas W G van Rhijn; Maximilian Burger; Arndt Hartmann
Journal:  Int Urol Nephrol       Date:  2016-12-29       Impact factor: 2.370

9.  [Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany].

Authors:  C Reek; M Rink; M Bloch; J Hansen; F K Chun; A Schneider; J Busche; M Fisch
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

Review 10.  High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.

Authors:  Oscar Rodriguez Faba; Joan Palou; Alberto Breda; H Villavicencio
Journal:  World J Urol       Date:  2012-10-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.